The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Efficacy of Intra-articular Injection of a Newly Developed Plasma Rich in Growth Factor (PRGF) Versus Hyaluronic Acid on Pain and Function of Patients with Knee Osteoarthritis: A Single-Blinded Randomized Clinical Trial
Open accessAbstract
Background and objectives: Knee osteoarthritis is the most common joint disease. We aimed to compare the efficacy and safety of intra-articular injection of a newly developed plasma rich in growth factor (PRGF) versus hyaluronic acid (HA) on pain and function of patients with knee osteoarthritis. Methods: In this single-blinded randomized clinical trial, patients with symptomatic osteoarthritis of knee were assigned to receive 2 intra-articular injections of our newly developed PRGF in 3 weeks or 3 weekly injections of HA. Our primary outcome was the mean change from baseline until 2 and 6 months post intervention in scores of visual analog scale, Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC), and Lequesne index. We used analysis of variance for repeated-measures statistical test. Results: A total of 69 patients entered final analysis. The mean age of patients was 58.2 ± 7.41 years and 81.2% were women. In particular, total WOMAC index decreased from 42.9 ± 13.51 to 26.8 ± 13.45 and 24.4 ± 16.54 at 2 and 6 months in the newly developed PRGF group (within subjects P = .001), and from 38.8 ± 12.62 to 27.8 ± 11.01 and 27.4 ± 11.38 at 2 and 6 months in the HA group (within subjects P = .001), respectively (between subjects P = .631). There was no significant difference between PRGF and HA groups in patients’ satisfaction and minor complications of injection, whereas patients in HA group reported significantly lower injection-induced pain. Conclusions: In 6 months follow up, our newly developed PRGF and HA, both are effective options to decrease pain and improvement of function in patients with symptomatic mild to moderate knee osteoarthritis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“with greater satisfaction reported in these groups compared to hyaluronic acid and ozone therapy.”
From Management of platelet-rich plasma and stem cells versus conventional treatments in musculoskeletal injury repair: A systematic review (2025) · cites this paper as [15]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Studies by Angoorani et al . and Raeissadat et al . analyzed PRP, PRGF, hyaluronic acid, and ozone therapy, demonstrating that PRP and PRGF achieved significant pain reduction (VAS: -41.1--52.3%, P < 0.001)”
From Management of platelet-rich plasma and stem cells versus conventional treatments in musculoskeletal injury repair: A systematic review (2025) · cites this paper as [15]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“and improvements in functionality (WOMAC: -36.2--55.3%, P < 0.001); [14,15]”
From Management of platelet-rich plasma and stem cells versus conventional treatments in musculoskeletal injury repair: A systematic review (2025) · cites this paper as [15]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“WOMAC: PRGF Δ-43.1%; VAS: Δ-41.0%.”
From Management of platelet-rich plasma and stem cells versus conventional treatments in musculoskeletal injury repair: A systematic review (2025) · cites this paper as [15]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“WOMAC: PRGF Δ-43.1%; VAS: Δ-41.0%.”
From Management of platelet-rich plasma and stem cells versus conventional treatments in musculoskeletal injury repair: A systematic review (2025) · cites this paper as [15]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hochberg, M. C., Altman, R. D., April, K. T., Benkhalti, M., Guyatt, G., McGowan, J., Towheed, T., Welch, V., Wells, G., & Tugwell, P. (2012) · Arthritis Care & Research · doi:10.1002/acr.21596 · Cited by 3,068
Dohan Ehrenfest, D. M., Rasmusson, L., & Albrektsson, T. (2009) · Trends in Biotechnology · doi:10.1016/j.tibtech.2008.11.009 · Cited by 2,008
Moreland, L. W. (2003) · Arthritis Research · doi:10.1186/ar623 · Cited by 777
Patel, S., Dhillon, M. S., Aggarwal, S., Marwaha, N., & Jain, A. (2013) · The American Journal of Sports Medicine · doi:10.1177/0363546512471299 · Cited by 762
Treatment of Osteoarthritis of the Knee: Evidence-Based Guideline, 2nd Edition
Jevsevar, D. S. (2013) · Journal of the American Academy of Orthopaedic Surgeons · doi:10.5435/00124635-201309020-00008 · Cited by 634
Viscosupplementation: a new concept in the treatment of osteoarthritis.
Balazs, E. A., & Denlinger, J. L. (1993) · PubMed · Cited by 595
The potential impact of the preparation rich in growth factors (PRGF) in different medical fields
Anitua, E., Sánchez, M., Orive, G., & Andía, I. (2007) · Biomaterials · doi:10.1016/j.biomaterials.2007.06.037 · Cited by 526
Anitua, E., Andí, I., Sanchez, M., Azofra, J., del Mar Zalduendo, M., de la Fuente, M., Nurden, P., & Nurden, A. T. (2005) · Journal of Orthopaedic Research · doi:10.1016/j.orthres.2004.08.015 · Cited by 505
Dai, W.-L., Zhou, A.-G., Zhang, H., & Zhang, J. (2017) · Arthroscopy: The Journal of Arthroscopic & Related Surgery · doi:10.1016/j.arthro.2016.09.024 · Cited by 444
Schmidt, M. B., Chen, E. H., & Lynch, S. E. (2006) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2005.10.011 · Cited by 415
Research works printed but not linked: 1
- 10.1517/14712598.2013.801450 · DOI
Cited by
Belk, J. W., Kraeutler, M. J., Houck, D. A., Goodrich, J. A., Dragoo, J. L., & McCarty, E. C. (2021) · The American Journal of Sports Medicine · doi:10.1177/0363546520909397 · Cited by 432
Filardo, G., Previtali, D., Napoli, F., Candrian, C., Zaffagnini, S., & Grassi, A. (2021) · CARTILAGE · doi:10.1177/1947603520931170 · Cited by 294
Raeissadat, S. A., Ghazi Hosseini, P., Bahrami, M. H., Salman Roghani, R., Fathi, M., Gharooee Ahangar, A., & Darvish, M. (2021) · BMC Musculoskeletal Disorders · doi:10.1186/s12891-021-04017-x · Cited by 181
“has shown that HA and PRGF had similar effects 2 and 6 months after with no meaningful difference between the groups [12].”
BackgroundSelf-citationHan, Y., Huang, H., Pan, J., Lin, J., Zeng, L., Liang, G., Yang, W., & Liu, J. (2019) · Pain Medicine · doi:10.1093/pm/pnz011 · Cited by 155
Chavda, S., Rabbani, S. A., & Wadhwa, T. (2022) · Cureus · doi:10.7759/cureus.24503 · Cited by 147
Metadata
- Authors
- Raeissadat, S. A., Rayegani, S. M., Ahangar, A. G., Abadi, P. H., Mojgani, P., & Ahangar, O. G.
- Affiliations
- Shahid Beheshti University (IR)
- University of Birmingham (GB)
- Rehabilitation and Medical Education Department, Iran Helal institute of Applied Sciences and Technology, affiliated to the Red Crescent Society of Iran, Tehran, Iran
- Corresponding author
- Ahangar, Azadeh Gharooee
- Venue
- Clinical Medicine Insights: Arthritis and Musculoskeletal Disorders
- Publisher
- SAGE Publications
- Published
- 2017-01
- Volume
- 10
- Pages
- 1179544117733452-1179544117733452
- ISSN
- 1178-1149 (ISSN-L)
- 1179-5441
- PMC
- PMC5638152
- OpenAlex
- W2761873219
- Cited by
- 70
- References
- 45
- Citations by year
- 2026: 3 · 2025: 8 · 2024: 9 · 2023: 5 · 2022: 5 · 2021: 10 · 2020: 17 · 2019: 7 · 2018: 6
- FWCI
- 11.48
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by-nc
- journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
- Locations
- Clinical Medicine Insights Arthritis and Musculoskeletal Disorders (publishedVersion, cc-by-nc)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Health Sciences › Dentistry › Periodontics › Periodontal Regeneration and Treatments
- Health Sciences › Medicine › Rheumatology › Osteoarthritis Treatment and Mechanisms
- Health Sciences › Medicine › Orthopedics and Sports Medicine › Tendon Structure and Treatment
- Keywords
- knee osteoarthritis, plasma rich in growth factors, hyaluronic acid, intra-articular injection, pain, functional outcome, WOMAC index, Lequesne index, injection complications, patient satisfaction
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Efficacy of Intra-articular Injection of a Newly Developed Plasma Rich in Growth Factor (PRGF) Versus Hyaluronic Acid on Pain and Function of Patients with Knee Osteoarthritis: A Single-Blinded Randomized Clinical Trial. https://app.cochat.ai/papers/10.1177/1179544117733452
- The paper
- Raeissadat, S. A., Rayegani, S. M., Ahangar, A. G., Abadi, P. H., Mojgani, P., & Ahangar, O. G. (2017). Efficacy of Intra-articular Injection of a Newly Developed Plasma Rich in Growth Factor (PRGF) Versus Hyaluronic Acid on Pain and Function of Patients with Knee Osteoarthritis: A Single-Blinded Randomized Clinical Trial. Clinical Medicine Insights: Arthritis and Musculoskeletal Disorders. https://doi.org/10.1177/1179544117733452
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.